CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 125 filers reported holding CYTOKINETICS INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,144,596 | -7.3% | 219,025 | 0.0% | 0.28% | -4.4% |
| Q1 2023 | $7,707,490 | +123.9% | 219,025 | +191.5% | 0.29% | +125.4% |
| Q4 2022 | $3,442,869 | -5.4% | 75,139 | 0.0% | 0.13% | -12.8% |
| Q3 2022 | $3,640,000 | -22.7% | 75,139 | -37.3% | 0.15% | -19.5% |
| Q2 2022 | $4,711,000 | +6.8% | 119,898 | 0.0% | 0.18% | +19.4% |
| Q1 2022 | $4,413,000 | +4.3% | 119,898 | +29.1% | 0.16% | +14.0% |
| Q4 2021 | $4,233,000 | +326.7% | 92,871 | -32.6% | 0.14% | +248.7% |
| Q1 2018 | $992,000 | -65.3% | 137,797 | -60.7% | 0.04% | -64.5% |
| Q4 2017 | $2,855,000 | – | 350,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |